Insider Stock Trading History of Bologna Thomas A


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Bologna Thomas A since year 2005. The trader's CIK number is 1232364. At the time of this reporting, Bologna Thomas A is the Director of Quotient Ltd . (stock ticker symbol QTNT). See this page for all insider trading activities at Quotient Ltd .

Note that in the past BOLOGNA THOMAS A also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Bologna Thomas A since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-10-31 QTNT Quotient Ltd Option Ex 3,909 .00 0
2016-10-31 QTNT Quotient Ltd Option Ex 1,291 .00 0
2015-01-22 QTNT Quotient Ltd Option Ex 40,029 .00 0
2012-02-02 RGDX Response Genetics Inc Buy 100,000 1.50 150,000
2011-05-19 SDIX Strategic Diagnostics Inc/de/ Buy 2,500 2.10 5,250
2010-08-26 ORCH Orchid Biosciences Inc Buy 1,000 1.42 1,420
2010-08-25 ORCH Orchid Biosciences Inc Buy 1,000 1.42 1,420
2010-08-23 ORCH Orchid Biosciences Inc Buy 1,000 1.48 1,480
2010-08-19 ORCH Orchid Biosciences Inc Buy 1,626 1.50 2,439
2009-09-03 ORCH Orchid Biosciences Inc Buy 3,600 1.58 5,688
2009-06-15 ORCH Orchid Biosciences Inc Buy 1,200 1.66 1,992
2009-06-10 ORCH Orchid Biosciences Inc Buy 2,400 1.48 3,552
2009-06-08 ORCH Orchid Biosciences Inc Buy 1,880 1.20 2,256
2008-08-06 ORCH Orchid Biosciences Inc Buy 2,000 3.30 6,600
2008-08-05 ORCH Orchid Biosciences Inc Buy 3,400 3.30 11,220
2007-11-06 ORCH Orchid Biosciences Inc Buy 3,322 4.59 15,247
2007-11-07 ORCH Orchid Biosciences Inc Buy 1,000 4.58 4,580

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bologna Thomas A (Director of Quotient Ltd at the time of this reporting) see the Securities and Exchange Commission (SEC) website.